Opportunity Information: Apply for PAR 21 097
The National Institutes of Health (NIH) funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)" (Funding Opportunity Number PAR-21-097; CFDA 93.273) is a discretionary grant program designed to support early-stage, planning-focused research on fetal alcohol spectrum disorders (FASD). The central purpose is to help investigators build the scientific and practical groundwork needed before launching larger, full-scale prevention or intervention trials. In other words, the R34 mechanism here is meant to fund the kinds of preparatory studies that reduce risk and uncertainty for a later, bigger project, such as refining an intervention, testing feasibility, establishing recruitment pipelines, validating outcome measures, or developing protocols and implementation plans that are strong enough to compete for and successfully run a subsequent large study.
The FOA prioritizes two broad and complementary research directions across the full lifespan. First, it supports prevention approaches that aim to reduce prenatal alcohol exposure and ultimately decrease the incidence of FASD. This can include work that identifies effective strategies to prevent alcohol use during pregnancy, improves screening and brief intervention models, strengthens referral and treatment linkages, or addresses social, behavioral, clinical, and structural drivers of prenatal alcohol exposure. Second, it supports interventions for individuals with FASD, which can span infancy through adulthood and may target cognitive, behavioral, emotional, physical, educational, social, or functional outcomes. The emphasis is on moving the field forward with practical, evidence-building steps that enable later definitive testing, rather than trying to complete a large efficacy or effectiveness trial within the R34 itself.
A key feature is that the FOA is labeled "Clinical Trial Optional," meaning applicants may propose a clinical trial if it fits the planning-grant purpose, but they are not required to do so. This flexibility allows projects that are strictly preparatory (for example, measure development, formative research, pilot implementation work, feasibility assessments, or small proof-of-concept studies) as well as projects that include a limited clinical trial component when that is the best way to answer a necessary planning question. The expectation remains that the work will directly position the team for a subsequent, larger-scale FASD prevention or intervention application, with clearer protocols, stronger justification for design choices, and stronger evidence that the approach is feasible, acceptable, and measurable.
The announcement also signals an alternative pathway for teams who want a staged, exploratory project structure: applicants interested in an exploratory phased approach can consider the R61/R33 option referenced in the FOA (PAR-21-NNN). That note is essentially guidance that, depending on the maturity of the concept and the desired milestone-driven progression, a different NIH mechanism might be a better fit than the R34 planning grant.
Eligibility is broad and intentionally inclusive, spanning governmental, academic, nonprofit, and private-sector organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in those categories); for-profit organizations other than small businesses; small businesses; and other categories. The FOA explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This wide eligibility aligns with the real-world nature of FASD prevention and intervention work, which often benefits from clinical-community partnerships, school and service system involvement, and culturally grounded approaches led by or co-developed with affected communities.
From an administrative standpoint, this is an NIH grant opportunity (Funding Instrument: Grant; Activity Category: Health) that was created on 2020-12-11, with an original closing date listed as 2023-10-17 in the provided source data. No award ceiling or expected number of awards is specified in the excerpt you provided, so applicants would typically consult the full FOA text and NIH institute/center guidance for budget and project period expectations typical of the R34 mechanism, as well as any institute-specific priorities related to FASD research.
Overall, the opportunity is best understood as a stepping-stone program: it funds the careful planning, piloting, and optimization work needed to produce a credible, scalable, and fundable next-stage proposal that can more definitively test prevention strategies to reduce prenatal alcohol exposure and FASD incidence, or interventions that improve outcomes for people living with FASD across the lifespan.Apply for PAR 21 097
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2020-12-11.
- Applicants must submit their applications by 2023-10-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)" (PAR-21-097; CFDA 93.273)
What is this funding opportunity?
This is a National Institutes of Health (NIH) discretionary grant opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)." It uses the R34 mechanism to support early-stage, planning-focused research related to fetal alcohol spectrum disorders (FASD).
What is the main purpose of the R34 in this FOA?
The purpose is to fund the preparatory work needed before launching a larger, full-scale prevention or intervention study. The emphasis is on building scientific and practical groundwork that reduces risk and uncertainty for a later, bigger project.
What kinds of "planning" activities does the FOA aim to support?
The FOA describes planning-oriented activities such as refining an intervention, testing feasibility, establishing recruitment pipelines, validating outcome measures, and developing protocols and implementation plans that are strong enough to support a subsequent large study.
Is the goal to run a full efficacy or effectiveness trial under this R34?
No. The FOA emphasizes practical, evidence-building steps that enable later definitive testing, rather than attempting to complete a large efficacy or effectiveness trial within the R34 itself.
What research areas does the FOA prioritize?
The FOA prioritizes two broad and complementary directions across the full lifespan: (1) prevention approaches to reduce prenatal alcohol exposure and decrease FASD incidence, and (2) interventions for individuals with FASD from infancy through adulthood.
What is meant by "prevention approaches" in this FOA?
Prevention approaches are studies aimed at reducing alcohol use during pregnancy and ultimately decreasing the incidence of FASD. Examples mentioned include improving screening and brief intervention models, strengthening referral and treatment linkages, and addressing social, behavioral, clinical, and structural drivers of prenatal alcohol exposure.
What is meant by "interventions for individuals with FASD" in this FOA?
Intervention research can span infancy through adulthood and may target outcomes such as cognitive, behavioral, emotional, physical, educational, social, or functional outcomes for individuals living with FASD.
Does the FOA require a clinical trial?
No. The FOA is labeled "Clinical Trial Optional," meaning a clinical trial may be proposed if it fits the planning-grant purpose, but a clinical trial is not required.
When might a clinical trial be appropriate under a "Clinical Trial Optional" R34?
A limited clinical trial component may be appropriate when it is the best way to answer a necessary planning question, while still keeping the project aligned with the planning and groundwork-building purpose of the R34.
What kinds of non-trial projects fit under this FOA?
The FOA indicates that strictly preparatory projects may be appropriate, including measure development, formative research, pilot implementation work, feasibility assessments, or small proof-of-concept studies, as long as they directly position the team for a subsequent larger-scale application.
What is the expected outcome of an R34 project funded under this FOA?
The expectation is that the work will directly position the team for a subsequent, larger-scale FASD prevention or intervention application with clearer protocols, stronger justification for design choices, and stronger evidence that the approach is feasible, acceptable, and measurable.
Does this FOA support work across the lifespan?
Yes. The FOA explicitly mentions research directions that can apply across the full lifespan, including interventions spanning infancy through adulthood.
Is there an alternative NIH mechanism mentioned for a staged, milestone-driven approach?
Yes. The FOA signals an alternative pathway for teams seeking an exploratory phased structure by referencing an R61/R33 option (PAR-21-NNN) as a potentially better fit depending on concept maturity and the desired milestone-driven progression.
Who is eligible to apply?
Eligibility is broad and includes governmental, academic, nonprofit, and private-sector organizations. The FOA includes a wide range of eligible applicant types, including U.S. and non-U.S. entities.
Are state and local government entities eligible?
Yes. Eligible applicants include state governments, county governments, city/township governments, special district governments, and independent school districts.
Are colleges and universities eligible?
Yes. Eligible applicants include public and state-controlled institutions of higher education and private institutions of higher education. The FOA also highlights eligibility for multiple categories of serving institutions and minority-serving institutions.
Are Tribal governments and Tribal organizations eligible?
Yes. The FOA includes federally recognized Native American tribal governments and tribal organizations that are not federally recognized, as well as Tribally Controlled Colleges and Universities (TCCUs).
Are nonprofits eligible (including those without 501(c)(3) status)?
Yes. The FOA includes nonprofits with or without 501(c)(3) status (excluding higher education institutions within those nonprofit categories, as stated in the provided information).
Are for-profit organizations eligible?
Yes. The FOA includes for-profit organizations other than small businesses, as well as small businesses.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly highlights faith-based or community-based organizations as eligible applicant types.
Are U.S. territories or possessions eligible?
Yes. The FOA highlights regional organizations and U.S. territories or possessions among eligible applicant types.
Are foreign (non-U.S.) organizations eligible?
Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) as eligible applicants.
What is the funding instrument and activity category?
The funding instrument is a Grant, and the activity category is Health.
What is the Funding Opportunity Number (FOA number) and CFDA number?
The Funding Opportunity Number is PAR-21-097, and the CFDA number listed is 93.273.
When was this opportunity created, and what closing date is listed?
The provided information states the opportunity was created on 2020-12-11, with an original closing date listed as 2023-10-17.
Is an award ceiling or expected number of awards provided in the excerpt?
No. The excerpt does not specify an award ceiling or the expected number of awards.
What should applicants do if they need budget and project period expectations?
Based on the excerpt, applicants would typically consult the full FOA text and NIH institute/center guidance for budget and project period expectations typical of the R34 mechanism, as well as any institute-specific priorities related to FASD research.
How should applicants think about the role of this FOA in a larger research plan?
The FOA is best understood as a stepping-stone program that funds careful planning, piloting, and optimization work to support a credible, scalable, and fundable next-stage proposal for larger FASD prevention or intervention research.
Browse more opportunities from the same category: Health
Next opportunity: FY 2021 Small Business Innovation Research (SBIR) Program Phase II
Previous opportunity: Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 097
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 097) also looked into and applied for these:
| Funding Opportunity |
|---|
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 21 098 Funding Number: PAR 21 098 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) Apply for PAR 21 064 Funding Number: PAR 21 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) Apply for PAR 21 063 Funding Number: PAR 21 063 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Health Services Quality Accelerator (HSQA) Apply for 72027821RFA00002 Funding Number: 72027821RFA00002 Agency: Jordan USAID-Amman Category: Health Funding Amount: $39,000,000 |
| NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) Apply for PAR 21 093 Funding Number: PAR 21 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) Apply for PAR 21 107 Funding Number: PAR 21 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional) Apply for RFA AA 21 001 Funding Number: RFA AA 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) Apply for PAR 21 121 Funding Number: PAR 21 121 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 006 Funding Number: RFA AG 22 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) Apply for RFA AI 21 001 Funding Number: RFA AI 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 010 Funding Number: RFA RM 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 21 009 Funding Number: RFA RM 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 008 Funding Number: RFA RM 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 033 Funding Number: RFA AG 21 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) Apply for PAR 21 089 Funding Number: PAR 21 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 21 109 Funding Number: PAR 21 109 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 21 010 Funding Number: RFA TR 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 21 108 Funding Number: PAR 21 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 21 083 Funding Number: PAR 21 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 21 082 Funding Number: PAR 21 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 097", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.